How We're Different
Offering study opportunities to patients is an important part of your oncology practice, however the complexities and administrative requirements have continued to escalate over the years. Fortunately, Pharmatech Oncology understands the growing concerns and has developed a method to simplify the logistics of conducting clinical studies. This avoids the challenges in the traditional site opening process.
There are no costs associated with being a Pharmatech Oncology Research Network member. We do not ask for an exclusive relationship and we manage much of the administrative burdens and permit the investigator and coordinators to focus on what is most important – patient care.
We support our network in a number of ways, including assisting network investigators with developing investigator sponsored trial concepts, which is unique to Pharmatech Oncology.
Pharmatech Oncology Announces Completion of SBIR Grant Research
10/19/2011
Pharmatech Oncology Announces ASH Abstract
10/11/2010
Press Release from Tamir Biotechnologies
7/6/2010
Pharmatech Oncology's Presentation at 46th Annual DIA Meeting
6/25/2010
Pharmatech Oncology to Present at 46th Annual DIA Meeting
6/10/2010
